Mechanism of action of Interferon and ribavirin in treatment of Hepatitis C

소개

Interferon and ribavirin 의 Hepatitis C 치료제로써의 작용기전 설명

목차

introduction
review

본문내용

This journal was published in 2005, reviewing and discussing about therapeutic mechanism of Ribavirin and Interferon alpa. Hepatitis C is a disease caused by a virus that infects the liver. In time, it can lead to permanent liver damage as well as cirrhosis, liver cancer, and liver failure. C until they already have some liver damage. This can take many years. Some people who get hepatitis C have it for a short time and then get better. This is called acute hepatitis C. But most people who are infected with the virus go on to develop long-term, or chronic, hepatitis C. In case of clinical research, half of the infected individuals with chronic disease do not achieve sustained clearance of hepatitis C virus. For the treatment of Hepatitis C, the combination of pegylated interferon with ribavirin is used generally, and it yields sustained response rates of 5456%. To achieve complete therapeutic goals for Hepatitis C, many researchers are studying about antiviral agents. Unfortunately, th

참고자료

· Nature, vol 436, 18 August 2005